Morphea
☆ AI Dermatology — Free Service
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Matetika, ny ratra amin'ny Morphea dia miseho ho toy ny paty misy pigmenta atrophika.
relevance score : -100.0%
ReferencesScleroderma dia aretina tsy fahita firy mahakasika ny tavy mifandray, miseho ho hoditra mafy ary indraindray miantraika amin'ny faritra hafa amin'ny vatana. Misy karazany roa lehibe: systemic sclerosis, izay misy ny fanamafisana ny hoditra sy ny taova anatiny, ary ny localized scleroderma, fantatra amin'ny anarana hoe morphea, izay mazàna mijanona ho voafetra amin'ny hoditra sy ny tavy ao ambaniny, miaraka amin'ny lalana tsara sy mametra tena. Na dia tsy fahita firy aza ny scleroderma eo an-toerana ary tsy fantatra mazava ny anton'izany, ny fikarohana vao haingana dia milaza fa mety hisy fiantraikany amin'ny taova anatiny ihany koa izy io ary miteraka olana ara-pahasalamana isan-karazany. Tena ilaina ny fitsaboana aloha mba hisorohana ny fahasarotana, indrindra raha jerena ny mety ho fahasarotana amin'ny localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea, fantatra amin'ny anarana hoe scleroderma localized, dia aretina autoimmune tsy fahita firy izay misy fiantraikany amin'ny tavy mifandray. Mety hiseho amin'ny fomba samihafa izy io, ary tsy dia mahazatra loatra, miaraka amin'ny tranga 0,4–2,7 isaky ny olona 100.000 isan-taona. Ny Morphea dia matetika hita amin'ny ankizy eo anelanelan'ny 2 ka hatramin'ny 14 taona, ary matetika misy fiantraikany amin'ny ankizivavy kokoa noho ny ankizilahy.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea dia aretina tsy fahita firy. Noho ny endriky ny sary, mety hanome vokatra diso ny algorithm rehefa mamaritra morphea.